Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.085
-0.025 (-2.25%)
Jul 6, 2026, 1:55 PM EDT - Market open
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $3.78 million as of July 6, 2026. Its market cap has increased by 13.97% in one year.
Market Cap
3.78M
Enterprise Value
-5.79M
1-Year Change
13.97%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has decreased from $5.88M to $3.78M, a decrease of -35.63%. That is a compound annual growth rate of -4.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 3.78M | 53.55% |
| Dec 31, 2025 | 2.46M | -28.01% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Creative Medical Technology Holdings | 4.47M |
| Alzamend Neuro | 4.41M |
| Revelation Biosciences | 4.22M |
| Ensysce Biosciences | 4.17M |
| GeoVax Labs | 4.13M |
| Matinas BioPharma Holdings | 4.06M |
| Propanc Biopharma | 4.03M |
| Decoy Therapeutics | 3.89M |